Literature DB >> 29630454

Human Vaccines & Immunotherapeutics: News.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29630454      PMCID: PMC5893196          DOI: 10.1080/21645515.2018.1453202

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  4 in total

1.  Autologous iPSC-Based Vaccines Elicit Anti-tumor Responses In Vivo.

Authors:  Nigel G Kooreman; Youngkyun Kim; Patricia E de Almeida; Vittavat Termglinchan; Sebastian Diecke; Ning-Yi Shao; Tzu-Tang Wei; Hyoju Yi; Devaveena Dey; Raman Nelakanti; Thomas P Brouwer; David T Paik; Idit Sagiv-Barfi; Arnold Han; Paul H A Quax; Jaap F Hamming; Ronald Levy; Mark M Davis; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2018-02-15       Impact factor: 24.633

2.  Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.

Authors:  Frederick F Lang; Charles Conrad; Candelaria Gomez-Manzano; W K Alfred Yung; Raymond Sawaya; Jeffrey S Weinberg; Sujit S Prabhu; Ganesh Rao; Gregory N Fuller; Kenneth D Aldape; Joy Gumin; Luis M Vence; Ignacio Wistuba; Jaime Rodriguez-Canales; Pamela A Villalobos; Clemens M F Dirven; Sonia Tejada; Ricardo D Valle; Marta M Alonso; Brett Ewald; Joanna J Peterkin; Frank Tufaro; Juan Fueyo
Journal:  J Clin Oncol       Date:  2018-02-12       Impact factor: 50.717

3.  Interim Estimates of 2017-18 Seasonal Influenza Vaccine Effectiveness - United States, February 2018.

Authors:  Brendan Flannery; Jessie R Chung; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard K Zimmerman; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Angie Foust; Wendy Sessions; LaShondra Berman; John R Barnes; Sarah Spencer; Alicia M Fry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-02-16       Impact factor: 17.586

4.  Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.

Authors:  Rajani Ravi; Kimberly A Noonan; Vui Pham; Rishi Bedi; Alex Zhavoronkov; Ivan V Ozerov; Eugene Makarev; Artem V Artemov; Piotr T Wysocki; Ranee Mehra; Sridhar Nimmagadda; Luigi Marchionni; David Sidransky; Ivan M Borrello; Evgeny Izumchenko; Atul Bedi
Journal:  Nat Commun       Date:  2018-02-21       Impact factor: 14.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.